Skip to main content
Log in

Notch1 Drives the Formation and Proliferation of Intrahepatic Cholangiocarcinoma

  • Published:
Current Medical Science Aims and scope Submit manuscript

Summary

The molecular mechanisms underlying the development of intrahepatic cholangiocarcinoma (ICC) are not clear yet. In this study, we investigated the involvement of Notch1 in the development of ICC. The cDNA microarray analysis showed that Notch1 expression was higher in ICC tissues than in normal biliary epithelial cells. Stable transfection of Notch1 receptor intracellular domain (NICD1) by hydrodynamic tail vein injection induced ICC formation in mice. Western blotting confirmed that Notch1 signaling was activated in human ICC cell lines and mouse ICC tissues. Silencing Notch1 with specific short interfering RNA (siRNA) inhibited the proliferation of ICC cells. Flow cytometry and Western blotting indicated that apoptosis was induced in Notch1-silenced ICC cells compared with controls. Additionally, Notch1 silencing was associated with the inhibition of hairy and enhancer of split-1 (Hes1) and activation of the phosphatase and tensin homolog (PTEN)/p53 pathway. Taken together, these data suggest that Notch1 drives ICC formation and proliferation; downregulation of Notch1 induces apoptosis in ICC cells; Notch1 signaling may serve as a novel therapeutic target for the treatment of ICC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Zhao Q, Yu WL, Lu XY, et al. Combined hepatocellular and cholangiocarcinoma originating from the same clone: a pathomolecular evidence-based study. Chin J Cancer, 2016,35(1):82–90

    Article  Google Scholar 

  2. Razumilava N, Gores GJ. Classification, diagnosis, and management of cholangiocarcinoma. Clin Gastroenterol Hepatol, 2013,11(1):13–21

    Article  Google Scholar 

  3. Razumilava N, Gores GJ. Cholangiocarcinoma. Lancet, 2014:2168–2179

  4. Wang FS, Fan JG, Zhang Z, et al. The global burden of liver disease: the major impact of China. Hepatology, 2014,60(6):2099–2108

    Article  Google Scholar 

  5. Esnaola NF, Meyer JE, Karachristos A, et al. Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma. Cancer, 2016,122(9):1349–1369

    Article  Google Scholar 

  6. Papatheodoridis GV, Lampertico P, Manolakopoulos S, et al. Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review. J Hepatol, 2010,53(2):348–356

    Article  CAS  Google Scholar 

  7. Alves RC, Alves D, Guz B, et al. Advanced hepatocellular carcinoma: Review of targeted molecular drugs. Ann Hepatol, 2011,10(1):21–27

    Article  Google Scholar 

  8. Belina F. Hilar cholangiocarcinoma (Klatskin tumor) - current treatment options. Rozhl Chir, 2013,92:4–15

    CAS  PubMed  Google Scholar 

  9. Yu Y, Wang L, Tang W, et al. RNA interference-mediated knockdown of Notch-1 inhibits migration and invasion, down-regulates matrix metalloproteinases and suppresses NF-kappaB signaling pathway in trophoblast cells. Acta Histochem, 2014,116(5):911–919

    Article  CAS  Google Scholar 

  10. Pupo M, Pisano A, Abonante S, et al. GPER activates Notch signaling in breast cancer cells and cancer-associated fibroblasts (CAFs). Int J Biochem Cell Biol, 2014,46:56–67

    Article  CAS  Google Scholar 

  11. Dahan S, Rabinowitz KM, Martin AP, et al. Notch-1 signaling regulates intestinal epithelial barrier function, through interaction with CD4+ T cells, in mice and humans. Gastroenterology, 2011,140:550–559

    Article  CAS  Google Scholar 

  12. Jensen J, Pedersen EE, Galante P, et al. Control of endodermal endocrine development by Hes-1. Nat Genet, 2000,24(1):36–44

    Article  CAS  Google Scholar 

  13. Sun YY, Li L, Liu XH, et al. The spinal notch signaling pathway plays a pivotal role in the development of neuropathic pain. Mol Brain, 2012,5:23–32

    Article  CAS  Google Scholar 

  14. Takebe N, Nguyen D, Yang SX. Targeting notch signaling pathway in cancer: clinical development advances and challenges. Pharmacol Ther, 2014,141(2):140–149

    Article  CAS  Google Scholar 

  15. Wolpin BM, Mayer RJ. A step forward in the treatment of advanced biliary tract cancer. N Engl J Med, 2010,362(14):1335–1337

    Article  CAS  Google Scholar 

  16. Binato M, Schmidt MK, Volkweis BS, et al. Mouse model of diethylnitrosamine-induced gastric cancer. J Surg Res, 2008,148(2):152–157

    Article  CAS  Google Scholar 

  17. Yang H, Li TW, Peng J, et al. A mouse model of cholestasis-associated cholangiocarcinoma and transcription factors involved in progression. Gastroenterology, 2011,141(1):378–388

    Article  CAS  Google Scholar 

  18. Ju HL, Han KH, Lee JD, et al. Transgenic mouse models generated by hydrodynamic transfection for genetic studies of liver cancer and preclinical testing of anticancer therapy. Int J Cancer, 2016,138(1):1601–1608

    Article  CAS  Google Scholar 

  19. Calvisi DF, Wang C, Ho C, et al. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma. Gastroenterology, 2011,140(3):1071–1083

    Article  CAS  Google Scholar 

  20. Chen X, Calvisi DF. Hydrodynamic transfection for generation of novel mouse models for liver cancer research. Am J Pathol, 2014,184(4):912–923

    Article  CAS  Google Scholar 

  21. Wang Y, Wang Y, Zhang L, et al. Endonuclease Restriction-Mediated Real-Time Polymerase Chain Reaction: A Novel Technique for Rapid, Sensitive and Quantitative Detection of Nucleic-Acid Sequence. Front Microbiol, 2016,7:1104–1114

    PubMed  PubMed Central  Google Scholar 

  22. Yuan X, Wu H, Xu H, et al. Notch signaling: an emerging therapeutic target for cancer treatment. Cancer Lett, 2015,369(1):20–27

    Article  CAS  Google Scholar 

  23. Kopan R, IIagan MX. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell, 2009,137(2):216–233

    Article  CAS  Google Scholar 

  24. Fan B, Malato Y, Calvisi DF, et al. Cholangiocarcinomas can originate from hepatocytes in mice. J Clin Invest, 2012,122(8):2911–2915

    Article  CAS  Google Scholar 

  25. O’Neil J, Calvo J, McKenna K, et al. Activating Notch1 mutations in mouse models of T-ALL. Blood, 2006,107(2):781–785

    Article  Google Scholar 

  26. Yan XQ, Sarmiento U, Sun Y, et al. A novel Notch ligand, Dll4, induces T-cell leukemia/lymphoma when overexpressed in mice by retroviral-mediated gene transfer. Blood, 2001,98(13):3793–3799

    Article  CAS  Google Scholar 

  27. Allen TD, Rodriguez EM, Jones KD, et al. Activated Notch1 induces lung adenomas in mice and cooperates with Myc in the generation of lung adenocarcinoma. Cancer Res, 2011,71(18):6010–6018

    Article  CAS  Google Scholar 

  28. Wang Z, Da Silva TG, Jin K, et al. Notch signaling drives stemness and tumorigenicity of esophageal adenocarcinoma. Cancer Res, 2014,74(21):6364–6374

    Article  CAS  Google Scholar 

  29. Gallahan D, Callahan R. The mouse mammary tumor associated gene INT3 is a unique member of the NOTCH gene family (NOTCH4). Oncogene, 1997,14(16):1883–1890

    Article  CAS  Google Scholar 

  30. Dill MT, Tornillo L, Fritzius T, et al. Constitutive Notch2 signaling induces hepatic tumors in mice. Hepatology, 2013,57(4):1607–1619

    Article  CAS  Google Scholar 

  31. Talora C, Sgroi DC, Crum CP, et al. Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation. Genes Dev, 2002,16(17):2252–2263

    Article  CAS  Google Scholar 

  32. Zweidler-McKay PA, He Y, Xu L, et al. Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignancies. Blood, 2005,106(12):3898–3906

    Article  CAS  Google Scholar 

  33. Aster JC, Pear WS, Blacklow SC. The Varied Roles of Notch in Cancer. Annu Rev Pathol, 2017,12:245–275

    Article  CAS  Google Scholar 

  34. Bolos V, Grego-Bessa J, de la Pompa JL. Notch signaling in development and cancer. Endocr Rev, 2008,28(3):339–363

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Feng Ye.

Additional information

Conflict of Interest Statement

The authors declare that they have no conflict of interest.

This work was supported by the National Natural Science Foundation of China (No. 81801621, No. 81572723, No. 81872253).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Guo, J., Fu, W., Xiang, M. et al. Notch1 Drives the Formation and Proliferation of Intrahepatic Cholangiocarcinoma. CURR MED SCI 39, 929–937 (2019). https://doi.org/10.1007/s11596-019-2125-0

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-019-2125-0

Key words

Navigation